| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.CARPATH.2006.01.001 |
| P698 | PubMed publication ID | 16697927 |
| P2093 | author name string | Petr Jarolim | |
| P433 | issue | 3 | |
| P921 | main subject | heart failure | Q181754 |
| biomarker | Q864574 | ||
| P304 | page(s) | 144-149 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Cardiovascular Pathology | Q1992658 |
| P1476 | title | Serum biomarkers for heart failure | |
| P478 | volume | 15 |
| Q44152089 | Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function. |
| Q48147437 | Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction |
| Q38623581 | In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio |
| Q38979036 | Mitogen-activated protein kinases pathways mediate the sunitinib-induced hypertrophy in rat cardiomyocyte H9c2 cells. |
| Q35596099 | Relation of natriuretic peptide concentrations to central sleep apnea in patients with heart failure. |
| Q37737495 | Role of urotensin II in health and disease |
| Q37230702 | The role of proteomics in clinical cardiovascular biomarker discovery. |
| Q88287377 | The value of urotensin II in patients with left-sided rheumatic valvular regurgitation |
Search more.